XML 33 R11.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Stockholders' Equity
6 Months Ended
Jun. 30, 2011
Stockholders' Equity
6. Stockholders’ Equity

Preferred Stock

On January 1, 2011, the Company granted 3,597 shares of Series B convertible preferred stock valued at $33,992 to the Series B convertible preferred stock owners as payment in kind for dividends

Stock Options

On February 11, 2011, the Company granted three members of the Board of Directors options to purchase an aggregate of 60,000 shares of common stock with an exercise price of $4.10 for a total value of $133,110 under a previously approved option plan.  The options vest over a three year period and have a term of ten years.

On February 11, 2011, the Company granted employees options to purchase an aggregate of 145,000 shares of common stock with an exercise price of $4.10 for a total value of $321,683 under a previously approved option plan. The options vest over a three year period and have a term of ten years.

On February 11, 2011, the Company granted outside consultants options to purchase an aggregate of 100,000 shares of common stock with an exercise price of $4.10 for a total value of $221,850 under a previously approved option plan. The options vest over a three year period and have a term of ten years.


Details of the options outstanding under all plans are as follows:

   
Shares
   
Weighted
Average
Exercise
Price
   
Weighted-
Average
Remaining
Contractual
Term
   
Aggregate
Intrinsic
Value
 
                          
Options outstanding at January 1, 2011
    1,996,300     $ 2.14       6.92       -  
Granted
    305,000     $ 4.10             -  
Expired
                      -  
Canceled
    (109,167 )   $ 2.23             -  
Exercised 
                      -  
Options outstanding at June 30, 2011
    2,192,133     $ 2.41       6.75     $ 5,672,059  
Options exercisable at June 30, 2011
    953,977     $ 1.68       5.68     $ 3,165,285  

Range of Exercise
 
Number
Outstanding
   
Weighted
Average
Remaining Years
of Contractual
Life
   
Weighted
Average
Exercise
Price
   
Number
Exercisable
   
Weighted
Average
Exercise
Price
 
                                
$0.80 – 2.00
    830,133       6.25     $ 1.39       652,341     $ 1.32  
$2.00 – 4.10
    1,362,000       7.05     $ 3.04       301,636     $ 2.46  
$0.80 – $4.10
    2,192,133       6.75     $ 2.41       953,977     $ 1.68  

Warrants

On May 13, 2011, the holder of warrants to purchase a total of 18,750 shares of the Company’s common stock, at an exercise price of $1.60 per share, elected to exercise the warrants on a cashless basis under the terms of the warrants.  The holder received a total of 14,135 net shares from the exercise.

Details of outstanding warrants are as follows:

   
Shares
   
Weighted
Average
Exercise Price
($)
   
Weighted-
Average
Remaining
Contractual
Term
   
Aggregate
Intrinsic
Value
 
Warrants outstanding at January 1, 2011
    1,915,340     $ 2.53       4.62        
Granted
    -       -       -       -  
Expired
    -       -       -       -  
Exercised 
    (18,750 )     -       -       -  
Warrants outstanding and exercisable at June 30, 2011
    1,896,590     $ 2.54       4.10     $ 4,668,180